We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $412M
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+15.49%
1 Year Est. Return
+28.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$412M
AUM Growth
+$70.8M
Cap. Flow
+$36.5M
Cap. Flow %
8.87%
Top 10 Hldgs %
4.34%
Holding
1,002
New
271
Increased
170
Reduced
168
Closed
234

Top Buys

Rank Stock Value
1
HBAN icon
Huntington Bancshares
HBAN
+$1.67M
2
DCI icon
Donaldson
DCI
+$1.6M
3
FDX icon
FedEx
FDX
+$1.6M
4
FNF icon
Fidelity National Financial
FNF
+$1.53M
5
GGG icon
Graco
GGG
+$1.51M

Top Sells

Rank Stock Value
1
CDNS icon
Cadence Design Systems
CDNS
+$1.48M
2
TIC
TIC Solutions Inc
TIC
+$1.48M
3
SDGR icon
Schrodinger
SDGR
+$1.27M
4
EXC icon
Exelon
EXC
+$1.23M
5
VC icon
Visteon
VC
+$1.22M

Sector Composition

Rank Sector Weight
1 Industrials 18.1%
2 Financials 16.8%
3 Healthcare 15.07%
4 Technology 12.86%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
R icon
326
Ryder
R
$9.53B
$496K 0.12%
1,881
LPTH icon
327
Lightpath Technologies
LPTH
$607M
$493K 0.12%
30,127
-33,512
-53% -$468K
WING icon
328
Wingstop
WING
$2.97B
$488K 0.12%
+2,816
New +$444K
FRSH icon
329
Freshworks
FRSH
$3.32B
$486K 0.12%
47,994
-27,138
-36% -$242K
CVCO icon
330
Cavco Industries
CVCO
$4.35B
$485K 0.12%
+789
New +$419K
BFST icon
331
Business First Bancshares
BFST
$1.04B
$485K 0.12%
15,774
WSFS icon
332
WSFS Financial
WSFS
$4.06B
$485K 0.12%
6,315
FBP icon
333
First Bancorp
FBP
$4.35B
$484K 0.12%
18,576
TWI icon
334
Titan International
TWI
$538M
$484K 0.12%
62,759
+34,225
+120% +$264K
LXEO icon
335
Lexeo Therapeutics
LXEO
$401M
$482K 0.12%
103,648
+87,088
+526% +$471K
FFIN icon
336
First Financial Bankshares
FFIN
$4.79B
$482K 0.12%
13,922
-11,644
-46% -$376K
BULL
337
Webull Corp
BULL
$5.26B
$481K 0.12%
73,709
AXS icon
338
AXIS Capital
AXS
$7.38B
$479K 0.12%
4,460
CTRE icon
339
CareTrust REIT
CTRE
$9.22B
$477K 0.12%
11,814
EC icon
340
Ecopetrol
EC
$35.5B
$477K 0.12%
33,466
+13,259
+66% +$192K
CLOV icon
341
Clover Health Investments
CLOV
$2.26B
$476K 0.12%
90,931
-65,586
-42% -$223K
FOR icon
342
Forestar Group
FOR
$1.42B
$476K 0.12%
+15,024
New +$413K
TIC
343
TIC Solutions Inc
TIC
$2.04B
$472K 0.11%
58,387
-175,099
-75% -$1.48M
WEAV icon
344
Weave Communications
WEAV
$586M
$471K 0.11%
78,708
+62,179
+376% +$339K
HOMB icon
345
Home BancShares
HOMB
$6.03B
$470K 0.11%
16,472
TTI icon
346
TETRA Technologies
TTI
$1.02B
$470K 0.11%
+41,492
New +$407K
TRNS icon
347
Transcat
TRNS
$800M
$468K 0.11%
5,041
MGTX icon
348
MeiraGTx Holdings
MGTX
$1.33B
$466K 0.11%
34,510
+2,578
+8% +$25.6K
IRON icon
349
Disc Medicine
IRON
$3.04B
$466K 0.11%
6,371
IBN icon
350
ICICI Bank
IBN
$109B
$464K 0.11%
+15,979
New +$432K

Similar funds

EntryPoint Capital's Q2 2026 Portfolio in Review

As of Q2 2026, EntryPoint Capital held 1,002 positions worth $412M, up 21% from $341M the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.

EntryPoint Capital deployed $36.5M of net new capital in Q2 2026, opening 271 new positions and adding to 170 existing holdings. Its largest new stake was Huntington Bancshares: 101,010 shares worth $1.79M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Cadence Design Systems, an estimated $1.48M trimmed.

  • EntryPoint Capital's largest Q2 2026 buy was Huntington Bancshares: 101,010 shares worth $1.79M.
  • EntryPoint Capital added most to Gilead Sciences in Q2 2026, an estimated $1.51M increase.
  • EntryPoint Capital's biggest Q2 2026 reduction was Cadence Design Systems, cutting an estimated $1.48M.
  • EntryPoint Capital fully exited Exelon in Q2 2026, selling an estimated $1.23M.
  • EntryPoint Capital's ten largest holdings make up 4.3% of its $412M portfolio in Q2 2026.
  • EntryPoint Capital opened 271 new positions and closed 234 in Q2 2026.
  • EntryPoint Capital's portfolio value rose 21% quarter-over-quarter to $412M.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.